Key facts
- Sooma Medical’s last known valuation is $17.6M (Mar 2024).
- It has raised $8.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include European Innovation Council, Innovestor, Business Finland, Lifeline Ventures, Verge Capital Management — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Sooma Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Sooma Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sooma Medical
Developer of non-invasive brain stimulation devices designed to treat neurological and psychiatric disorders. The company offers neurological therapy devices for non-invasive treatment options for selected disorders affecting the central nervous system, along with other effective medical devices, enabling physicians to change psychiatric and neurological care with accessible therapies at home.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2013
- Employees
- 22
- Website
- soomamedical.com/
- Ownership
- Privately Held (backing)
Sooma Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sooma Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sooma Medical in its N-PORT filings yet. We sweep new filings monthly.